Pharmacokinetics, Antitumor Activity, and Safety of ODM-201 in Patients with Chemotherapy-naive Metastatic Castration-resistant Prostate Cancer: An Open-label Phase 1 Study

Christophe Massard; Heidi M. Penttinen; Egils Vjaters; Petri Bono; Vilnis Lietuvietis; Teuvo L. Tammela; Annamari Vuorela; Pirjo Nykanen; Pasi Pohjanjousi; Amir Snapir; Karim Fizazi

doi:10.1016/j.eururo.2015.09.046

Pharmacokinetics, Antitumor Activity, and Safety of ODM-201 in Patients with Chemotherapy-naive Metastatic Castration-resistant Prostate Cancer: An Open-label Phase 1 Study

Christophe Massard, Heidi M. Penttinen, Egils Vjaters, Petri Bono, Vilnis Lietuvietis, Teuvo L. Tammela, Annamari Vuorela, Pirjo Nykanen, Pasi Pohjanjousi, Amir Snapir, Karim Fizazi

Forskningsoutput: Tidskriftsbidrag › Artikel › Vetenskaplig › Peer review

Originalspråk	engelska
Tidskrift	European Urology
Volym	69
Nummer	5
Sidor (från-till)	834-840
Antal sidor	7
ISSN	0302-2838
DOI	https://doi.org/10.1016/j.eururo.2015.09.046
Status	Publicerad - maj 2016
MoE-publikationstyp	A1 Tidskriftsartikel-refererad

Vetenskapsgrenar

3126 Kirurgi, anestesiologi, intensivvård, radiologi

Åtkomst av dokument

10.1016/j.eururo.2015.09.046

Pharmacokinetics, Antitumor ActivitySlutlig publicerad version, 972 KB

Citera det här

Massard, C., Penttinen, H. M., Vjaters, E., Bono, P., Lietuvietis, V., Tammela, T. L., Vuorela, A., Nykanen, P., Pohjanjousi, P., Snapir, A., & Fizazi, K. (2016). Pharmacokinetics, Antitumor Activity, and Safety of ODM-201 in Patients with Chemotherapy-naive Metastatic Castration-resistant Prostate Cancer: An Open-label Phase 1 Study. European Urology, 69(5), 834-840. https://doi.org/10.1016/j.eururo.2015.09.046

@article{6473020254064eff9d4d7769023ce5d7,

title = "Pharmacokinetics, Antitumor Activity, and Safety of ODM-201 in Patients with Chemotherapy-naive Metastatic Castration-resistant Prostate Cancer: An Open-label Phase 1 Study",

keywords = "Androgen receptor inhibitor, Castration-resistant prostate cancer, ODM-201, ENZALUTAMIDE, ANTIANDROGEN, SURVIVAL, ARN-509, 3126 Surgery, anesthesiology, intensive care, radiology",

author = "Christophe Massard and Penttinen, {Heidi M.} and Egils Vjaters and Petri Bono and Vilnis Lietuvietis and Tammela, {Teuvo L.} and Annamari Vuorela and Pirjo Nykanen and Pasi Pohjanjousi and Amir Snapir and Karim Fizazi",

year = "2016",

month = may,

doi = "10.1016/j.eururo.2015.09.046",

language = "English",

volume = "69",

pages = "834--840",

journal = "European Urology",

issn = "0302-2838",

publisher = "Elsevier Scientific Publ. Co",

number = "5",

}

Massard, C, Penttinen, HM, Vjaters, E, Bono, P, Lietuvietis, V, Tammela, TL, Vuorela, A, Nykanen, P, Pohjanjousi, P, Snapir, A & Fizazi, K 2016, 'Pharmacokinetics, Antitumor Activity, and Safety of ODM-201 in Patients with Chemotherapy-naive Metastatic Castration-resistant Prostate Cancer: An Open-label Phase 1 Study', European Urology, vol. 69, nr. 5, s. 834-840. https://doi.org/10.1016/j.eururo.2015.09.046

Pharmacokinetics, Antitumor Activity, and Safety of ODM-201 in Patients with Chemotherapy-naive Metastatic Castration-resistant Prostate Cancer : An Open-label Phase 1 Study. / Massard, Christophe; Penttinen, Heidi M.; Vjaters, Egils et al.

I: European Urology, Vol. 69, Nr. 5, 05.2016, s. 834-840.

Forskningsoutput: Tidskriftsbidrag › Artikel › Vetenskaplig › Peer review

TY - JOUR

T1 - Pharmacokinetics, Antitumor Activity, and Safety of ODM-201 in Patients with Chemotherapy-naive Metastatic Castration-resistant Prostate Cancer

T2 - An Open-label Phase 1 Study

AU - Massard, Christophe

AU - Penttinen, Heidi M.

AU - Vjaters, Egils

AU - Bono, Petri

AU - Lietuvietis, Vilnis

AU - Tammela, Teuvo L.

AU - Vuorela, Annamari

AU - Nykanen, Pirjo

AU - Pohjanjousi, Pasi

AU - Snapir, Amir

AU - Fizazi, Karim

PY - 2016/5

Y1 - 2016/5

KW - Androgen receptor inhibitor

KW - Castration-resistant prostate cancer

KW - ODM-201

KW - ENZALUTAMIDE

KW - ANTIANDROGEN

KW - SURVIVAL

KW - ARN-509

KW - 3126 Surgery, anesthesiology, intensive care, radiology

U2 - 10.1016/j.eururo.2015.09.046

DO - 10.1016/j.eururo.2015.09.046

M3 - Article

VL - 69

SP - 834

EP - 840

JO - European Urology

JF - European Urology

SN - 0302-2838

IS - 5

ER -